For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted ...

Weight-loss drugs that mimic the effect of regulatory hormones on appetite and energy balance often come with a few rather ...